Dr Rob van der Pluijm from MORU (Mahidol Oxford Research Unit) in Bangkok, Thailand, tells us about his work as project coordinator in mapping resistance to antimalarials
Tracking antimalarial resistance and treatment of malaria using Triple ACTs
Loading Video...
Anti-malaria drug resistance is spreading throughout Southeast Asia and we need to find new treatments. Our researchers at MORU use a combination of artemisinin and two partner drugs instead of one. If confirmed safe and tolerable, triple artemisinin combination therapies might be a good option to treat multi-drug resistant malaria, as well as slow down the emergence and spread of anti-malarial resistance.
Series:
People:
Oxford Unit:
More in this Series...
Malaria is an endemic disease in much of the world, and is a major contributor to child and infant mortality in many countries. Our malaria podcasts describe efforts by NDM clinicians and scientists, in Oxford and around the world, to treat and prevent malaria, including vaccine development, parasitology, and improved treatment for severe malaria, with the aim to lessen the disease burden on some of the world's most vulnerable people.
Subscribe
Download Media
- Video (40.67 MB)